These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

140 related articles for article (PubMed ID: 12033750)

  • 1. Adolescent kleptomania treated with naltrexone--a case report.
    Grant JE; Kim SW
    Eur Child Adolesc Psychiatry; 2002 Apr; 11(2):92-5. PubMed ID: 12033750
    [TBL] [Abstract][Full Text] [Related]  

  • 2. A case of kleptomania and compulsive sexual behavior treated with naltrexone.
    Grant JE; Kim SW
    Ann Clin Psychiatry; 2001 Dec; 13(4):229-31. PubMed ID: 11958364
    [TBL] [Abstract][Full Text] [Related]  

  • 3. An open-label study of naltrexone in the treatment of kleptomania.
    Grant JE; Kim SW
    J Clin Psychiatry; 2002 Apr; 63(4):349-56. PubMed ID: 12000210
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Pharmacological treatment of kleptomania--review].
    Kozian R; Otto FG
    Psychiatr Prax; 2003 May; 30(4):216-20. PubMed ID: 12768528
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Exposure and response prevention therapy augmented with naltrexone in kleptomania: a controlled case study using galvanic skin response for monitoring.
    Olbrich S; Jahn I; Stengler K
    Behav Cogn Psychother; 2019 Sep; 47(5):622-627. PubMed ID: 30894239
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Naltrexone for High-Dose Venlafaxine-Associated Kleptomania.
    Mouaffak F
    J Clin Psychopharmacol; 2020; 40(3):315-316. PubMed ID: 32332474
    [No Abstract]   [Full Text] [Related]  

  • 7. Outcome study of kleptomania patients treated with naltrexone: a chart review.
    Grant JE
    Clin Neuropharmacol; 2005; 28(1):11-4. PubMed ID: 15711433
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Kleptomania: diagnosis and treatment options.
    Durst R; Katz G; Teitelbaum A; Zislin J; Dannon PN
    CNS Drugs; 2001; 15(3):185-95. PubMed ID: 11463127
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Kleptomania after head trauma: two case reports and combination treatment strategies.
    Aizer A; Lowengrub K; Dannon PN
    Clin Neuropharmacol; 2004; 27(5):211-5. PubMed ID: 15602100
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Kleptomania treated with naltrexone in a patient with intellectual disability.
    Mouaffak F; Hamzaoui S; Kebir O; Laqueille X
    J Psychiatry Neurosci; 2020 Jan; 45(1):71-72. PubMed ID: 31845772
    [No Abstract]   [Full Text] [Related]  

  • 11. Naltrexone treatment of kleptomania: a case report.
    Çetinay Aydın P; Belkız Güngör B; Gülseren L
    Turk Psikiyatri Derg; 2012; 23(4):284-6. PubMed ID: 23225130
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Naltrexone for impulse control disorders in Parkinson disease: a placebo-controlled study.
    Galduróz JC; Ramos AC; Santos-Galduróz RF
    Neurology; 2015 Mar; 84(13):1386-7. PubMed ID: 25825466
    [No Abstract]   [Full Text] [Related]  

  • 13. Naltrexone for impulse control disorders in Parkinson disease: a placebo-controlled study.
    Liang JW; Shanker VL; Groves M
    Neurology; 2015 Mar; 84(13):1386-7. PubMed ID: 25992401
    [No Abstract]   [Full Text] [Related]  

  • 14. Naltrexone for impulse control disorders in Parkinson disease: a placebo-controlled study.
    Weintraub D; Papay K; Xie SX
    Neurology; 2015 Mar; 84(13):1386-7. PubMed ID: 25992402
    [No Abstract]   [Full Text] [Related]  

  • 15. A double-blind, placebo-controlled study of the opiate antagonist, naltrexone, in the treatment of kleptomania.
    Grant JE; Kim SW; Odlaug BL
    Biol Psychiatry; 2009 Apr; 65(7):600-6. PubMed ID: 19217077
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Kleptomania: clinical characteristics and treatment].
    Grant JE; Odlaug BL
    Braz J Psychiatry; 2008 May; 30 Suppl 1():S11-5. PubMed ID: 17713696
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Topiramate for the treatment of kleptomania: a case series and review of the literature.
    Dannon PN
    Clin Neuropharmacol; 2003; 26(1):1-4. PubMed ID: 12567156
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Understanding and treating kleptomania: new models and new treatments.
    Grant JE
    Isr J Psychiatry Relat Sci; 2006; 43(2):81-7. PubMed ID: 16910369
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Opioid antagonists in broadly defined behavioral addictions: a narrative review.
    Piquet-Pessôa M; Fontenelle LF
    Expert Opin Pharmacother; 2016; 17(6):835-44. PubMed ID: 26798982
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The treatment of kleptomania with serotonin reuptake inhibitors.
    Lepkifker E; Dannon PN; Ziv R; Iancu I; Horesh N; Kotler M
    Clin Neuropharmacol; 1999; 22(1):40-3. PubMed ID: 10047933
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.